An Ontario pharmaceutical company has become the first in Canada to receive Health Canada approval to manufacture cannabis-based prescription drugs in its facility. Burlington’s EmpowerPharm, a new clinical-stage, Canadian-owned drug company, made the announcement this week. Organic weed? See how 48North’s Good Farm is cultivating sun-grown, outdoor cannabis |… While the company was …Read More »
This story originally appeared on The Economic Times. The Haryana government has allowed reimbursement of goods and service tax paid by companies, non-governmental organisations and individuals on purchase of 15 items including Covid vaccines, remdesivir injections, ventilators and oxygen cylinders that they have donated free of cost to the state …Read More »
This story originally appeared on InvestmentNews. Financial services companies have generally adopted remote work policies, but as offices reopen, the next issue becomes who is and isn’t vaccinated. As more people receive vaccinations and local economies start to slowly reopen, the broader financial services industry is preparing for how and when to start bringing …Read More »
This story originally appeared on Cannabis & Tech today. Cannabis and innovation go hand-in-hand. From growing to packaging technology, consuming to creating, cannabis influences many innovative ideas. Innovation in cannabis isn’t always as visible as it is in other industries. Cannabis is still budding and because it’s been illegal for so …Read More »
This story originally appeared on The Fresh Toast. Despite more Americans supporting federal legalization of cannabis, many people still don’t know about the industry’s potential to harm the environment. Just like other agricultural commodities, there are environmental impacts involved when growing cannabis. But many consumers don’t know, or simply don’t care …Read More »
This story originally appeared on Investor´s Business Daily. Moderna stock posted a 66% gain in January as its coronavirus vaccine gained authorizations in a wide swath of countries, including the United States. Moderna (MRNA) joined Pfizer (PFE) and partner BioNTech (BNTX) with a Food and Drug Administration authorized Covid-19 vaccine in December. Both vaccines use …Read More »
This story originally appeared on Yahoo Finance. Every week, Benzinga conducts a survey to collect sentiment on what traders are most excited about; interested in; or thinking about when they are managing and building their personal portfolios. Electric vehicle manufacturers and EV service companies continue to be in the spotlight …Read More »
This story originally appeared on The Fresh Toast. As time goes on, alternative plant medicine, such as cannabis, are slowly changing the way pain management is viewed and executed. Did you know that in 2019, chronic pain impacted one-third of the U.S. population? This number continues to rise, and so does the …Read More »
This story originally appeared on BNN Bloomerg. NORTH AMERICAN MARKETS (SPTSX:IND) U.S. stocks fluctuated ahead of major earnings reports while Europe’s equity benchmark advanced on merger news. The dollar slipped. Big tech names were the best performers on the S&P 500 Index, with the wider market weighed down by worries …Read More »
At their core, private placements are fairly simple to understand — they are essentially offerings in which securities are sold to a small number of accredited investors. This story originally appeared on Investing News. At their core, private placements are fairly simple to understand — they are essentially offerings in which securities …Read More »
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!